Diagnosis And Treatment Of Atopic Dermatitis In Children: A Comprehensive Review Of Clinical Strategies
DOI:
https://doi.org/10.55204/trc.v3i2.e279Keywords:
Atopic Dermatitis, Atopic Eczema, Infantile Eczema, ChildrenAbstract
Introduction: Atopic dermatitis (AD) is a most common inflammatory skin disease; which has a substantial impact on the quality of life of patients. Without clear diagnostic tests, the clinical diagnosis and natural history of the disease and with medical evaluation is the Gold Standard for its diagnosis. Treatment options for pediatric patients with AD are very limited.
Development: This is an article reviewing the documents of scientific societies dedicated to the care of atopic dermatitis in children, as well as systematic reviews and current scientific studies was carried out through the search engines SCOPUS, WOS and Pubmed and Google Scholar both in Spanish. like in English.
Practical applications: In recent years, new treatments have come onto the market for use in AD in children. Additionally, many emerging topical and systemic agents are described. that are being investigated.
Conclusions: Atopic dermatitis is a common dermatological disease in childhood worldwide. The use of diagnostic criteria allows us to determine the index of severity and the treatment regimen for this disease. For treatment, corticosteroids and tacrolimus are the mainstay. Currently, results are expected from different emerging treatments with promising efficacy and safety profiles.
Downloads
References
Bylund S, Von Kobyletzki LB, Svalstedt M, Svensson Å. Prevalence and Incidence of Atopic Dermatitis: A Systematic Review. Acta Derm Venereol. 2020;100(12):5765. doi:10.2340/00015555-3510
Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet Lond Engl. 2020;396(10247):345-360. doi:10.1016/S0140-6736(20)31286-1
Silverberg JI, Barbarot S, Gadkari A, et al. Atopic dermatitis in the pediatric population: A cross-sectional, international epidemiologic study. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2021;126(4):417-428.e2. doi:10.1016/j.anai.2020.12.020
Katoh N, Ohya Y, Ikeda M, et al. Japanese guidelines for atopic dermatitis 2020. Allergol Int Off J Jpn Soc Allergol. 2020;69(3):356-369. doi:10.1016/j.alit.2020.02.006
Siegels D, Heratizadeh A, Abraham S, et al. Systemic treatments in the management of atopic dermatitis: A systematic review and meta-analysis. Allergy. 2021;76(4):1053-1076. doi:10.1111/all.14631
Fishbein AB, Silverberg JI, Wilson EJ, Ong PY. Update on Atopic Dermatitis: Diagnosis, Severity Assessment, and Treatment Selection. J Allergy Clin Immunol Pract. 2020;8(1):91-101. doi:10.1016/j.jaip.2019.06.044
Eichenfield LF, Stripling S, Fung S, Cha A, O’Brien A, Schachner LA. Recent Developments and Advances in Atopic Dermatitis: A Focus on Epidemiology, Pathophysiology, and Treatment in the Pediatric Setting. Paediatr Drugs. 2022;24(4):293-305. doi:10.1007/s40272-022-00499-x
Wan J, Oganisian A, Spieker AJ, et al. Racial/Ethnic Variation in Use of Ambulatory and Emergency Care for Atopic Dermatitis among US Children. J Invest Dermatol. 2019;139(9):1906-1913.e1. doi:10.1016/j.jid.2019.02.024
Kim Y, Blomberg M, Rifas-Shiman SL, et al. Racial/ethnic differences in incidence and persistence of childhood atopic dermatitis. J Invest Dermatol. 2019;139(4):827-834. doi:10.1016/j.jid.2018.10.029
Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: Clinical implications. Allergy Asthma Proc. 2019;40(2):84-92. doi:10.2500/aap.2019.40.4202
Renert-Yuval Y, Thyssen JP, Bissonnette R, et al. Biomarkers in atopic dermatitis—a review on behalf of the International Eczema Council. J Allergy Clin Immunol. 2021;147(4):1174-1190.e1. doi:10.1016/j.jaci.2021.01.013
Brunner PM, Israel A, Zhang N, et al. Early-onset pediatric atopic dermatitis is characterized by TH2/TH17/TH22-centered inflammation and lipid alterations. J Allergy Clin Immunol. 2018;141(6):2094-2106. doi:10.1016/j.jaci.2018.02.040
Li H, Zhang Z, Zhang H, Guo Y, Yao Z. Update on the Pathogenesis and Therapy of Atopic Dermatitis. Clin Rev Allergy Immunol. 2021;61(3):324-338. doi:10.1007/s12016-021-08880-3
Wang V, Boguniewicz J, Boguniewicz M, Ong PY. The infectious complications of atopic dermatitis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2021;126(1):3-12. doi:10.1016/j.anai.2020.08.002
Blicharz L, Rudnicka L, Samochocki Z. Staphylococcus aureus: an underestimated factor in the pathogenesis of atopic dermatitis? Postepy Dermatol Alergol. 2019;36(1):11-17. doi:10.5114/ada.2019.82821
Wang Q, Liu L, Gao S, Su S. Guidelines for the Management of Atopic Dermatitis in Children: A Systematic Review. Int Arch Allergy Immunol. 2023;184(2):132-141. doi:10.1159/000527007
Yang YB, Gohari A, Lam J. Brief Academic Review and Clinical Practice Guidelines for Pediatric Atopic Dermatitis. Curr Pediatr Rev. 2021;17(3):229-237. doi:10.2174/1573396316999200820163434
Lara-Corrales I, Bergman JN, Landells I, Ramien ML, Lansang P. Approach to the Assessment and Management of Pediatric Patients With Atopic Dermatitis: A Consensus Document. Section I: Overview of Pediatric Atopic Dermatitis. J Cutan Med Surg. 2019;23(5_suppl):3S-11S. doi:10.1177/1203475419882049
Torres T, Ferreira EO, Gonçalo M, Mendes-Bastos P, Selores M, Filipe P. Update on Atopic Dermatitis. Acta Med Port. 2019;32(9):606-613. doi:10.20344/amp.11963
Goh MS, Yun JS, Su JC. Management of atopic dermatitis: a narrative review. Med J Aust. 2022;216(11):587-593. doi:10.5694/mja2.51560
Puar N, Chovatiya R, Paller AS. New treatments in atopic dermatitis. Ann Allergy Asthma Immunol Off Publ Am Coll Allergy Asthma Immunol. 2021;126(1):21-31. doi:10.1016/j.anai.2020.08.016
Atopic dermatitis endotypes and implications for targeted therapeutics. - Abstract - Europe PMC. Accessed November 25, 2023. https://europepmc.org/article/med/30612663
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Andrea Valeria Andrango Catota, Gennys María Gutiérrez Ramírez, Eurídice Alejandra Cabrera Cabrera, Nicolas Felipe Larrea Parra, Lourdes Michelle Reyes Alban, Kattherine Jennyfer Salazar Muñoz
This work is licensed under a Creative Commons Attribution 4.0 International License.
The authors retain the moral and patrimonial rights of their works. They only give to the magazine Tesla Revista Científica the right to the first publication of this. Since Tesla Revista Científica is an open access publication, readers can fully or partially reproduce its content as long as they properly credit the corresponding authors and the journal itself. Tesla Revista Científica undertakes not to make commercial use of the texts it receives and/or publishes.
Our journal is governed by the international policies SHERPA/RoMEO: Green journal: They allow the self-archiving of both the pre-print (draft of a paper) and the post-print (the version corrected and reviewed by peers) and even the final version ( layout as it will be published in the journal).
See also "Copyright and licences".
